Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

1143studies shown

Showing 1,021-1,032 of 1,143

Drug study icon

CompletedNCT01022229

The Safety and Efficacy of a Compound Natural Health Product in Children With Attention Deficit Hyperactivity Disorder (ADHD)

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

ADHDOtherFrom 6 Years to 12 Years

Countries: Canada
Sponsor: The Canadian College of Naturopathic Medicine
Condition: ADHD

Drug study icon

Active Not RecruitingNCT04950868

Effectiveness of quetiapine in depression

This study is active but not recruiting in Canada. It is testing quetiapine for depression.

In Canada

DepressionDrugFrom 18 Years to 45 Years

Countries: Canada
Sponsor: Verinder Sharma
Condition: Depression

Behavioral study icon

TerminatedNCT01324297

The Topical Niacin Skin Flush Test in First Episode Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

SchizophreniaBehavioralFrom 19 Years to 30 Years

Countries: Canada
Sponsor: Nova Scotia Health Authority
Condition: Schizophrenia

Drug study icon

CompletedNCT03151681

The Trauma of Betrayal: Treating Adjustment Disorder With Reconsolidation Blockade Under Propranolol

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

PTSDDrugFrom 18 Years to 65 Years

Countries: Canada
Sponsor: Douglas Mental Health University Institute
Condition: PTSD

Behavioral study icon

CompletedNCT05670405

The Trauma PORTAL Project: a Virtual Asynchronous Treatment for Interpersonal Trauma

This summary needs review. Please check the official study record and contact the research team for details.

Remote / online

PTSDBehavioralOver 18 Years

Countries: Canada
Sponsor: Women's College Hospital
Condition: PTSD

Device study icon

UnknownNCT02542709

The Use of Noninvasive Brain Stimulation in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

PTSDDeviceFrom 18 Years to 60 Years

Countries: Canada
Sponsor: Laval University
Condition: PTSD

Behavioral study icon

CompletedNCT00992979

Therapeutic Massage to Manage Withdrawal Related Anxiety

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

AnxietyBehavioralFrom 18 Years to 65 Years

Countries: Canada
Sponsor: Dalhousie University
Condition: Anxiety

Behavioral study icon

CompletedNCT03053362

THINC-it Vortioxetine - Sensitivity to Change

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

DepressionBehavioralFrom 18 Years to 65 Years

Countries: Canada
Sponsor: Brain and Cognition Discovery Foundation
Condition: Depression

Behavioral study icon

CompletedNCT03483701

Thinking Skills at Work: Cognitive Remediation Therapy for people with Serious Mental Illness

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

SchizophreniaBehavioralFrom 19 Years to 60 Years

Countries: Canada
Sponsor: Fraser Health
Condition: Schizophrenia

Behavioral study icon

TerminatedNCT03230097

This Study Tests Whether BI 409306 Prevents people with a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year

This study was terminated in the United States, in Canada, in the United Kingdom, .... It focuses on Schizophrenia.

In Canada

SchizophreniaBehavioralFrom 16 Years to 30 Years

Countries: United States, Canada, United Kingdom, ...
Sponsor: Boehringer Ingelheim
Condition: Schizophrenia

Drug study icon

TerminatedNCT03351244

This Study Tests Whether BI 409306 Prevents people with Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months

This study was terminated in the United States, in France, in Canada, .... It focuses on schizophrenia.

In Canada

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States, France, Canada, ...
Sponsor: Boehringer Ingelheim
Condition: Schizophrenia

Drug study icon

CompletedNCT03859973

This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in people with Schizophrenia

This study is completed in the United States, in Australia, in France, .... It focuses on schizophrenia.

In Canada

SchizophreniaDrugFrom 18 Years to 50 Years

Countries: United States, Australia, France, ...
Sponsor: Boehringer Ingelheim
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.